That's a conundrum, when we talk about decriminalization. People generally have to get the supply from the illegal market, and right now in Canada, the illegal market is a contaminated market.
I'm not suggesting that we should not decriminalize. Decriminalization is really saying as a society that we're all going to work together as institutional partners—health and enforcement and police—and treat this as a health issue and that someone is not going to end up in the criminal justice system just for possessing small amounts of these substances for their own personal use. It's a huge signal to people.
It still leaves us with the problem of the source of the drugs. That's why, as Karen Turner has been suggesting, we have to look at that side of the equation too. There needs to be a safe supply of substances for people who we know are going to use them.
It's really an ethical choice for us: to allow people to continue to use the contaminated, illegal, deadly market, or to offer them substances that are very common substances in our medicine cabinets and our pharmacies today—some of the stimulants that Ms. Turner was talking about.
There are, then, two different issues, and I think there are ethical questions around both.